Navigation Links
Mylan to Speak at the Goldman Sachs 34th Annual Global Healthcare Conference
Date:6/12/2013

PITTSBURGH, June 12, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that Executive Chairman Robert Coury and Chief Financial Officer John Sheehan will speak at the Goldman Sachs 34th Annual Global Healthcare Conference on Wednesday, June 12, 2013 at 10 a.m. PDT, 1 p.m. EDT, at the Terranea Resort, Rancho Palos Verdes, California. The conference will be webcast live and can be accessed on Mylan's Investor Relations Web site at http://investor.mylan.com/. The webcast also can be accessed at the following URL:

http://cc.talkpoint.com/gold006/061113a_gm/?entity=28_WOF84U4

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of approximately 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com


'/>"/>
SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
2. Mylan Specialty L.P. Announces Partnership with Baseball Teams Across Country to Raise Awareness of Potentially Life-Threatening Allergies
3. Presenting Sponsor Mylan Specialty L.P. Calls on Communities Nationwide to Join The Food Allergy Research & Education (FARE) Walk for Food Allergy
4. Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
5. Deborah Autor, FDAs Deputy Commissioner for Global Regulatory Operations and Policy, to Join Mylan
6. Mylan Announces $1 Million Gift to The Pittsburgh Promise Scholarship Fund
7. Mylan Schedules First Quarter 2013 Financial Results Conference Call and Live Webcast
8. Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2012
9. Mylan Reports a 23% Increase in Fourth Quarter 2012 Adjusted Diluted EPS to $0.65
10. Mylan Launches Innovative Portfolio of Antiretroviral Products for Treatment of HIV/AIDS in South Africa
11. Mylan Enhances Partnership with Biocon through Strategic Collaboration for Insulin Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... and VANCOUVER, British Columbia , March ... SPHS ) (the "Company" or "Sophiris"), a clinical late-stage ... urological diseases, today announced that data from its successful ... as a focal treatment for localized prostate cancer, will ... at the 32 nd Annual European Association of ...
(Date:3/23/2017)... March 23, 2017  Ethicon* today announced the ... a privately held medical device company that manufactures ... the surgical treatment of Gastroesophageal Reflux Disease (GERD). ... expanding its portfolio of minimally invasive options for ... Financial terms of the transaction have not been ...
(Date:3/23/2017)... SILVER, N.J. , March 23, 2017 /PRNewswire/ ... company, today announced that it has kicked off ... into their 3D printed bone segments. ... Engineering, "Our unique variable honeycomb lattice structures have ... in-growth as compared to current allograft wedges from ...
Breaking Medicine Technology:
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... the year of enhancements, upgrading their training and leads programs. , In February, ... Reserved for elite sales agents, Performance Partners is designed to teach how to ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding Christ ... #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion with God. ... with God #TruthwithGrace” is the creation of published author Lea Michelle Johnson, a ...
(Date:3/24/2017)... ... 2017 , ... “Vintage and Harvest A Cultivation of Christian Love” is the ... in North Carolina with his wife, Anna Marie. He and his wife are the ... is also the author of “Shadow and Substance.” , “Love, the agape kind, is ...
(Date:3/24/2017)... , ... March 24, 2017 , ... “The Adventures of ... smart and silly dog who lives his life to the fullest, as God intended. ... published author Patti Holmgren, a mother and grandmother pursuing her passion for writing, especially ...
(Date:3/23/2017)... ... ... A recent report from the National Council on Teacher Quality (NCTQ) advocates ... based on a review of GPA and SAT/ACT requirements at 221 institutions in 25 ... argues that this higher bar should be set by states, by the Council for ...
Breaking Medicine News(10 mins):